A Phase II Study of Epratuzumab, Rituximab (ER)-CHOP for Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
Phase of Trial: Phase II
Latest Information Update: 24 Dec 2015
At a glance
- Drugs Epratuzumab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 21 Dec 2009 Results presented at the 51st Annual Meeting of the American Society of Hematology (ASH-2009).
- 26 May 2009 Status changed from active, no longer recruiting to completed, as reported by an Immunomedics media release.
- 18 May 2009 Final results presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, reported by Mayo Clinic.